Analysts have been eager to weigh in on the Healthcare sector with new ratings on Seagen (SGEN) and Agios Pharma (AGIO).
Seagen (SGEN)
Oppenheimer analyst Jay Olson assigned a Buy rating to Seagen yesterday and set a price target of $208.00. The company’s shares closed last Thursday at $139.23, close to its 52-week low of $134.51.
According to TipRanks.com, Olson is a 4-star analyst with an average return of 5.1% and a 47.5% success rate. Olson covers the Healthcare sector, focusing on stocks such as Constellation Pharmaceuticals, Madrigal Pharmaceuticals, and Frequency Therapeutics.
Seagen has an analyst consensus of Moderate Buy, with a price target consensus of $185.92.
See today’s analyst top recommended stocks >>
Agios Pharma (AGIO)
Oppenheimer analyst Mark Breidenbach maintained a Hold rating on Agios Pharma yesterday. The company’s shares closed last Thursday at $55.78, close to its 52-week high of $58.93.
According to TipRanks.com, Breidenbach is a 5-star analyst with an average return of 19.5% and a 44.0% success rate. Breidenbach covers the Healthcare sector, focusing on stocks such as Forma Therapeutics Holdings, Global Blood Therapeutics, and Iovance Biotherapeutics.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Agios Pharma with a $60.80 average price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
